In search of a ‘pan-European value set’; application for EQ-5D-3L by Sajjad, A, Versteegh, MM, Santi, I, Busschbach, J, Simon, J, Roijen, LH-V

Cost-effectiveness analysis of treating patients with ntrk-positive cancer with the histology-independent therapy entrectinib by Huygens, S, Vellekoop, H, Versteegh, M, Santi, I, Szilberhorn, L, Zelei, T, Nagy, B, Tsiachristas, A, Koleva-Kolarova, R, Wordsworth, S, Rutten-van Mölken, M